Stemmatters
PrivateLast Round
Grant
Nov 25, 2025
Total Funding Raised
$2.36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Stemmatters is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) specializing in regenerative medicine, advanced cell therapies, and biological products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stemmatters Comparables
Compare Stemmatters with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cellab CDMO | 88% | |
| Histocell | 87% | |
| HiTech Health | 85% |
Stemmatters Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 25, 2025 | ||||
| Grant | Jun 22, 2023 | ||||
| Grant | Oct 1, 2022 | ||||
| Grant | Apr 15, 2022 | ||||
| Series A | Sep 16, 2011 |
Stemmatters Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Caixa Capital | Series A |
| Eurostars SME programme | Grant |
| Beta Capital | Series A |
| Pathena | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 45% MoM.
- May 21, 2026
Grew 18% QoQ, from 39 to 46 employees.
Stemmatters Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Stemmatters's valuation, stock price, and market status.
Is Stemmatters a public or private company?
Stemmatters is a private company.
What is the current stock price of Stemmatters?
Stemmatters is a private company, so its shares have no public market price. Caplight tracks Stemmatters's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stemmatters worth (valuation)?
Valuation information for Stemmatters is not publicly available.
Can I buy Stemmatters stock?
Stemmatters shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stemmatters's last funding round?
Stemmatters's most recent funding round was Grant on November 25, 2025.
Who are the main investors in Stemmatters?
Key investors in Stemmatters include European Innovation Council Fund, Caixa Capital, Eurostars SME programme, Beta Capital, Pathena.
Will Stemmatters IPO soon?
No public IPO plans have been announced for Stemmatters.
How can I track Stemmatters secondary market activity?
Caplight tracks bids, offers, and trades in Stemmatters's shares on secondary markets.